News Article
Dynavax Announces FDA Approval of HEPLISAV-B™ for Prevention of Hepatitis B in Adults
Posted on April 10, 2019
Blog:
add description
Sign up to receive updates on new CIFOR resources, funding opportunities, and events.
Posted on April 10, 2019
Blog:
add description